EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Impact of Genotype–Phenotype Associations on Prognosis in Dilated Cardiomyopathy

Sophie L V M Stroeks iD, Ping Wang, Marco Merlo, Steven Muller, Alessia Paldino, Nerea Mora-Ayestaran, Max Jason, Matteo Dal Ferro, Carola Pio Loco Detto Gava, Fernando Dominguez, Esther Gonzalez-Lopez, Arthur van den Wijngaard und 16 weitere

European Journal of Heart Failure · 2025

DOI: 10.1002/ejhf.70040 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Sophie L V M Stroeks und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Maastricht University, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Dilated cardiomyopathy (DCM) has a monogenic aetiology in up to 40% of patients. Understanding the spectrum of genotype–phenotype associations in DCM is crucial for risk stratification and personalized treatment. We aimed to (i) characterize genotype-specific features, (ii) evaluate whether phenotype-based clustering reflects underlying genotype, and (iii) compare the prognostic value of genotype- versus phenotype-based approaches. Methods and results A multicentre cohort of 534 DCM patients with a (likely) pathogenic variant were grouped by genotype (genotype-first approach) and clustered by clinical phenotype (phenotype-first approach). We compared clinical characteristics, identified genotype–phenotype associations, and evaluated outcomes, including all-cause mortality, heart failure hospitalization, heart transplantation, and malignant ventricular arrhythmias. Using the genotype-first approach, significant genotype–phenotype associations were found for 10 genes. FLNC, LMNA, DSP, and PLN variants were linked to arrhythmias. BAG3, TNNT2, DMD, and TTN were associated with increased cardiac volumes and decreased left ventricular ejection fraction (LVEF). Clustering identified four phenotypic clusters: (1) young, moderately reduced LVEF; (2) arrhythmias, moderate reduced LVEF; (3) low LVEF; (4) arrhythmias, low LVEF. There were no clear correlations between phenotypic clusters and genotype. The genotype-first approach showed that LMNA, FLNC, and BAG3 variants had the highest risk for heart failure and arrhythmogenic adverse outcomes. The phenotype-first approach indicated that clusters 3 and 4 were associated with the worst prognosis. Overall, genotype was the strongest predictor of outcome.

Conclusions

Patients with a genetic form of DCM exhibit clinical and genetic heterogeneity. Genotype-based risk stratification is more accurate compared to a phenotype-first approach, highlighting the importance of broad genetic screening among patients with DCM. Additionally, gene-specific risk prediction should become more prominent in current guidelines on management of genetic DCM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedHumansMaleFemalePrognosisMiddle AgedPhenotypeGenetic Association StudiesAdultGenotypeStroke VolumeVentricular Function, LeftLamin Type AAdaptor Proteins, Signal TransducingArrhythmias, CardiacAgedConnectin

Stichwörter der Autor:innen

Dilated cardiomyopathyGeneticsPrognosisRisk prediction

Substanzen

Lamin Type AAdaptor Proteins, Signal TransducingConnectin

Autor:innen und Institutionen

  • Department of Cardiology, Maastricht University, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.
  • KU Leuven, Cardiovascular Sciences, Leuven, Belgium.
  • Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Members of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).
  • Department of Cardiology, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.

ORCID-Profile: Sophie L V M Stroeks

Zitieren

APA

Stroeks, S. L. V. M., Wang, P., Merlo, M., Muller, S., Paldino, A., Mora-Ayestaran, N., Jason, M., Ferro, M. D., Pio Loco Detto Gava, C., Dominguez, F., Gonzalez-Lopez, E., van den Wijngaard, A., Venner, M. F. G. H. M., Sikking, M., Minten, M., Nihant, B., Beelen, N., Graw, S., Medo, K., …, & Verdonschot, J. A. J. (2025). Impact of Genotype–Phenotype Associations on Prognosis in Dilated Cardiomyopathy. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.70040

Vancouver

Stroeks SLVM, Wang P, Merlo M, Muller S, Paldino A, Mora-Ayestaran N, et al. Impact of Genotype–Phenotype Associations on Prognosis in Dilated Cardiomyopathy. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.70040

BibTeX
@article{Stroeks2025,
  author = {Stroeks, Sophie L V M and Wang, Ping and Merlo, Marco and Muller, Steven and Paldino, Alessia and Mora-Ayestaran, Nerea and Jason, Max and Ferro, Matteo Dal and Pio Loco Detto Gava, Carola and Dominguez, Fernando and Gonzalez-Lopez, Esther and van den Wijngaard, Arthur and Venner, Max F G H M and Sikking, Maurits and Minten, Michiel and Nihant, Bastien and Beelen, Nina and Graw, Sharon and Medo, Kristen and de Koning, Bart and Taylor, Matthew and van Tintelen, J Peter and Mestroni, Luisa and Sinagra, Gianfranco and Te Riele, Anneline S J M and Garcia-Pavia, Pablo and Heymans, Stephane and Verdonschot, Job A J},
  title = {Impact of Genotype–Phenotype Associations on Prognosis in Dilated Cardiomyopathy},
  journal = {European Journal of Heart Failure},
  year = {2025},
  doi = {10.1002/ejhf.70040}
}
Kostenlos starten →